Showing results (521-530 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|October 30, 2007
Penetration of prulifloxacin into gynaecological tissues after single and repeated oral administrationsFranco Gorlero, Paola Lorenzi, Maria Teresa Rosignoli, et al.Drugs in R&D|October 30, 2007
Amoxicillin pulsatile - MiddleBrook: APC 111, APC-111, PULSYS-enhanced amoxicillinDrugs in R&D|August 30, 2008
Applications of metabolomics in drug discovery and developmentDavid S WishartDrugs in R&D|August 30, 2008
Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteersDesmond Padhi, Maggi Salfi, Maurice EmeryDrugs in R&D|July 1, 2008
Fragment-based approach to drug lead discovery: overview and advances in various techniquesDaniela Fattori, Antonella Squarcia, Sandra BartoliDrugs in R&D|November 8, 2008
New approaches to the treatment of inflammatory disease : focus on small-molecule inhibitors of signal transduction pathwaysY A Ivanenkov, K V Balakin, S E TkachenkoDrugs in R&D|November 8, 2008
Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-o-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg : randomized, double-blind, placebo-controlled, crossover study in healthy subjectsManuel Vaz-da-Silva, Ana I Loureiro, Teresa Nunes, et al.Drugs in R&D|September 5, 2007
Efficacy and tolerability of hyaluronan (ialuset) in the treatment of pressure ulcers: a multicentre, non-randomised, pilot studyBrigitte Barrois, Muriel Carles, Michel Rumeau, et al.Drugs in R&D|September 5, 2007
Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humansChen ChenPageof 90